Abstract:• Hyperammonemia is critical to the development of hepatic encephalopathy (HE) but multiple factors contribute to its pathophysiology, including the gut microbiome. • Traditional treatments of HE such as lactulose and rifaximin target hyperammonemia. • Nontraditional treatments are broadly classified into gut microbiome modulation, ammonia detoxification, and procedural treatments. • Many nontraditional treatments such as fecal microbiota transplant, l -ornithine l -aspartate, glycerol phenylbutyrate, and Hyperammonemia is critical to the development of hepatic encephalopathy (HE) but multiple factors contribute to its pathophysiology, including the gut microbiome. Traditional treatments of HE such as lactulose and rifaximin target hyperammonemia. Nontraditional treatments are broadly classified into gut microbiome modulation, ammonia detoxification, and procedural treatments. Many nontraditional treatments such as fecal microbiota transplant, l -ornithine l -aspartate, glycerol phenylbutyrate, and

Nontraditional Treatment of Hepatic Encephalopathy